Results 91 to 100 of about 1,854,692 (262)

Effect of chemical treatments on OCC properties. Project 2697-3, report two : a progress report to the Fourdrinier Kraft Board Group of the American Paper Institute

open access: yes, 1980
"May 19, 1980.""The Institute of Paper Chemistry, Betty John ... William J. Whitsitt ... Clyde H. Sprague.
John, Betty M.   +2 more
core  

Prediction of optical variations in paper from high resolution measurements of paper properties

open access: yes, 2013
A method to predict optical variations from high resolution measurementsof paper properties is evaluated in this work. The method combines thepoint-wise values of high resolution maps of filler content and grammagewith an empirical model derived in an ...
Edström, Per   +6 more
core   +1 more source

Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To delineate specific in vivo white matter pathology in neuronal intranuclear inclusion disease (NIID) using diffusion spectrum imaging (DSI) and define its clinical relevance. Methods DSI was performed on 42 NIID patients and 38 matched controls.
Kaiyan Jiang   +10 more
wiley   +1 more source

Chemithermomechanical Pulping and Properties Comparison of Four Common Hardwood Species in Northern China

open access: yesBioResources
Populus cathayana Rehder (PCR, Chinese poplar), Fraxinus chinensis Roxb. (FCR, Chinese ash), Platanus orientalis L. (PO, Oriental plane), and Acer palmatum Thunb. (AP, Japanese maple) are four common hardwoods in the northern hemisphere.
Chuanmin Geng   +7 more
doaj  

Epilepsy‐Associated Variants of a Single SCN1A Codon Exhibit Divergent Functional Properties

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Pathogenic variants in SCN1A, which encodes the voltage‐gated sodium channel NaV1.1, are associated with multiple epilepsy syndromes exhibiting a range of clinical severity. SCN1A variants are reported in different syndromes, including Dravet syndrome, which is associated with loss‐of‐function, whereas neonatal/infantile‐onset ...
Lanie N. Liebovitz   +3 more
wiley   +1 more source

Status reports to the Paper Physics Project Advisory Committee

open access: yes, 1991
"April 4, 1991."On-line measurement of paper properties: project 3332 / M. Hall, P. Brodeur, T. Jackson ; Process, properties, product relationships: project 3467 / P. Brodeur, M. Hall, T.
Sarfarazi, Mohsen Paul.   +7 more
core  

Physics and intrinsic properties [PDF]

open access: yes, 2013
The paper sketches out an ontology of physics in terms of matter being primitive stuff distributed in space and all the properties physics is committed to being dispositions that fix the temporal development of the distribution of matter in space ...
Michael Esfeld, Esfeld, Michael
core  

Characterization of Cocoa (Theobroma cacao L.) Wood Branches as a Potential Resource for Paper Production

open access: yesBioResources
For sustainable use of lignocellulosic resources, pruned tree branches of cocoa, one of the major evergreen tropical tree crops with significant economic importance worldwide, were investigated as a potential source of kraft pulp.
Laura Andze   +6 more
doaj  

Development of Paper Utilizing Miscanthus Pulp Combined with Waste Paper for the Production of Packaging

open access: yesApplied Sciences
Much focus is being dedicated to the development of innovative technologies for producing biodegradable polymers from plant biomass. It is proposed that annual and perennial herbaceous plants, such as miscanthus, be used as promising sources of cellulose.
Yulia Sevastyanova   +13 more
doaj   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy